FB2024_03 , released June 25, 2024
Human Disease Model Report: proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome
Open Close
General Information
Name
proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome
FlyBase ID
FBhh0001487
Overview

The report describes a model that allows characterization of disease-implicated variants associated with the human genes FLVCR2 and FLVCR1. Most residues mutated in FLVCR1 and FLVCR2 in the context of disease are conserved in the Drosophila histamine transporter HisT, suggesting that these sites may play critical roles in substrate transport.

FLVCR2 is implicated in proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH); PVHH exhibits autosomal recessive inheritance. FLVCR2 encodes a protein that acts as an importer of heme and as a transporter for a calcium-chelator complex. A mutation of HisT analogous to the disease-implicated variant FLVCR2:p.Pro280Arg has been characterized in flies; see the 'Disease-Implicated Variants' table below.

A UAS construct of the human gene Hsap\FLVCR2 has been introduced into flies, but has not been characterized; a stock is available.

[updated Nov. 2022 by FlyBase; FBrf0222196]

Disease Summary Information
Disease Summary: proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome
OMIM report

[PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH](https://omim.org/entry/225790)

Human gene(s) implicated

[FLVCR HEME TRANSPORTER 2; FLVCR2](https://omim.org/entry/610865)

Symptoms and phenotype

Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome is a rare usually prenatally lethal disorder characterized by hydranencephaly, a distinctive glomerular vasculopathy in the central nervous system and retina, and diffuse ischemic lesions of the brain stem, basal ganglia, and spinal cord with calcifications. It is usually diagnosed by ultrasound between 26 and 33 weeks' gestation (summary by Meyer et al., 2010; pubmed:20206334). Rarely, affected individuals may survive, but are severely impaired with almost no neurologic development (Kvarnung et al., 2016; pubmed:25677735). [from MIM:225790; 2022.11.20]

Genetics

Proliferative vasculopathy and hydranencephaly-hydrocephaly syndrome (PVHH), also known as encephaloclastic proliferative vasculopathy, is caused by homozygous or compound heterozygous mutation in the FLVCR2 gene. [from MIM:225790; 2022.11.20]

Cellular phenotype and pathology
Molecular information

FLVCR2 encodes a transmembrane protein of the major facilitator superfamily; acts as an importer of heme and as a transporter for a calcium-chelator complex, which is important for growth and calcium metabolism. [GeneCards, FLVCR2; 2022.11.20]

External links
Disease synonyms
encephaloclastic proliferative vasculopathy
EPV
Fowler syndrome
hydrocephaly, Fowler type
PVHH
Ortholog Information
Human gene(s) in FlyBase
Human gene (HGNC)
D. melanogaster ortholog (based on DIOPT)
Comments on ortholog(s)

Many to one: 2 human genes to 1 Drosophila gene.

Other mammalian ortholog(s) used
    D. melanogaster Gene Information (1)
    Cellular component (GO)
    Gene Groups / Pathways
    Comments on ortholog(s)

    High-scoring ortholog of human FLVCR2 and FLVCR1 (1 Drosophila to 2 human).

    Orthologs and Alignments from DRSC
    DIOPT - DRSC Integrative Ortholog Prediction Tool - Click the link below to search for orthologs in Humans
    Other Genes Used: Viral, Bacterial, Synthetic (0)
      Summary of Physical Interactions (0 groups)
      Alleles Reported to Model Human Disease (Disease Ontology) (0 alleles)
      Alleles Representing Disease-Implicated Variants
      Genetic Tools, Stocks and Reagents
      Sources of Stocks
      Contact lab of origin for a reagent not available from a public stock center.
      Bloomington Stock Center Disease Page
      Related mammalian, viral, bacterial, or synthetic transgenes
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila transgenes
      Allele
      Transgene
      Publicly Available Stocks
      RNAi constructs available
      Allele
      Transgene
      Publicly Available Stocks
      Selected Drosophila classical alleles
      Allele
      Allele class
      Mutagen
      Publicly Available Stocks
      amorphic allele - molecular evidence
      CRISPR/Cas9
      amorphic allele - molecular evidence
      CRISPR/Cas9
      References (5)